113 related articles for article (PubMed ID: 38823030)
21. Guideline-Adherent Clinical Validation of a Comprehensive 170-Gene DNA/RNA Panel for Determination of Small Variants, Copy Number Variations, Splice Variants, and Fusions on a Next-Generation Sequencing Platform in the CLIA Setting.
Boyle TA; Mondal AK; Saeed-Vafa D; Ananth S; Ahluwalia P; Kothapalli R; Chaubey A; Roberts E; Qin D; Magliocco AM; Rojiani AM; Kolhe R
Front Genet; 2021; 12():503830. PubMed ID: 34093633
[TBL] [Abstract][Full Text] [Related]
22. Pitfalls of using polymerase chain reaction-based assays for JAK2 and CALR exon 9 variant testing in myeloproliferative neoplasms: Knowing when to go the extra mile!
Krishnamurthy K; Chai J; Wang Y; Naeem R; Goldstein DY
Am J Clin Pathol; 2024 Feb; 161(2):155-161. PubMed ID: 37788380
[TBL] [Abstract][Full Text] [Related]
23. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
[TBL] [Abstract][Full Text] [Related]
24. Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes.
Yeo ZX; Wong JC; Rozen SG; Lee AS
BMC Genomics; 2014 Jun; 15(1):516. PubMed ID: 24962530
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
Hwang SM; Lee KC; Lee MS; Park KU
Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
[TBL] [Abstract][Full Text] [Related]
26. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
[TBL] [Abstract][Full Text] [Related]
27. Detection of Circulating Tumor DNA with a Single-Molecule Sequencing Analysis Validated for Targeted and Immunotherapy Selection.
Atkins A; Gupta P; Zhang BM; Tsai WS; Lucas J; Javey M; Vora A; Mei R
Mol Diagn Ther; 2019 Aug; 23(4):521-535. PubMed ID: 31209714
[TBL] [Abstract][Full Text] [Related]
28. Routine use of the Ion Torrent AmpliSeq™ Cancer Hotspot Panel for identification of clinically actionable somatic mutations.
Tsongalis GJ; Peterson JD; de Abreu FB; Tunkey CD; Gallagher TL; Strausbaugh LD; Wells WA; Amos CI
Clin Chem Lab Med; 2014 May; 52(5):707-14. PubMed ID: 24334431
[TBL] [Abstract][Full Text] [Related]
29. Integration of Technical, Bioinformatic, and Variant Assessment Approaches in the Validation of a Targeted Next-Generation Sequencing Panel for Myeloid Malignancies.
Thomas M; Sukhai MA; Zhang T; Dolatshahi R; Harbi D; Garg S; Misyura M; Pugh T; Stockley TL; Kamel-Reid S
Arch Pathol Lab Med; 2017 Jun; 141(6):759-775. PubMed ID: 28557600
[TBL] [Abstract][Full Text] [Related]
30. From Forensics to Clinical Research: Expanding the Variant Calling Pipeline for the Precision ID mtDNA Whole Genome Panel.
Cortes-Figueiredo F; Carvalho FS; Fonseca AC; Paul F; Ferro JM; Schönherr S; Weissensteiner H; Morais VA
Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769461
[TBL] [Abstract][Full Text] [Related]
31. Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data.
Wang Q; Kotoula V; Hsu PC; Papadopoulou K; Ho JWK; Fountzilas G; Giannoulatou E
BMC Med Genomics; 2019 Dec; 12(Suppl 9):181. PubMed ID: 31874647
[TBL] [Abstract][Full Text] [Related]
32. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.
Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R
Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059
[TBL] [Abstract][Full Text] [Related]
33. Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform.
Deshpande A; Lang W; McDowell T; Sivakumar S; Zhang J; Wang J; San Lucas FA; Fowler J; Kadara H; Scheet P
BMC Bioinformatics; 2018 Jan; 19(1):5. PubMed ID: 29301485
[TBL] [Abstract][Full Text] [Related]
34. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
[TBL] [Abstract][Full Text] [Related]
35. Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies.
Bhai P; Hsia CC; Schenkel LC; Hedley BD; Levy MA; Kerkhof J; Santos S; Stuart A; Lin H; Broadbent R; Nan S; Yang P; Xenocostas A; Chin-Yee I; Sadikovic B
Mol Diagn Ther; 2022 May; 26(3):333-343. PubMed ID: 35381971
[TBL] [Abstract][Full Text] [Related]
36. Clinical Evaluation of a Novel Nine-Gene Panel for Ion Torrent PGM Sequencing of Myeloid Malignancies.
Ivanova M; Shivarov V; Pavlov I; Lilakos K; Naumova E
Mol Diagn Ther; 2016 Feb; 20(1):27-32. PubMed ID: 26476543
[TBL] [Abstract][Full Text] [Related]
37. Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.
Dumur CI; Almenara JA; Powers CN; Ferreira-Gonzalez A
Diagn Pathol; 2015 Sep; 10():169. PubMed ID: 26376646
[TBL] [Abstract][Full Text] [Related]
38. Comparison and evaluation of two exome capture kits and sequencing platforms for variant calling.
Zhang G; Wang J; Yang J; Li W; Deng Y; Li J; Huang J; Hu S; Zhang B
BMC Genomics; 2015 Aug; 16(1):581. PubMed ID: 26242175
[TBL] [Abstract][Full Text] [Related]
39. Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation.
Heydt C; Wölwer CB; Velazquez Camacho O; Wagener-Ryczek S; Pappesch R; Siemanowski J; Rehker J; Haller F; Agaimy A; Worm K; Herold T; Pfarr N; Weichert W; Kirchner T; Jung A; Kumbrink J; Goering W; Esposito I; Buettner R; Hillmer AM; Merkelbach-Bruse S
BMC Med Genomics; 2021 Feb; 14(1):62. PubMed ID: 33639937
[TBL] [Abstract][Full Text] [Related]
40. Analytical Validation of Clinical Whole-Genome and Transcriptome Sequencing of Patient-Derived Tumors for Reporting Targetable Variants in Cancer.
Wrzeszczynski KO; Felice V; Abhyankar A; Kozon L; Geiger H; Manaa D; London F; Robinson D; Fang X; Lin D; Lamendola-Essel MF; Khaira D; Dikoglu E; Emde AK; Robine N; Shah M; Arora K; Basturk O; Bhanot U; Kentsis A; Mansukhani MM; Bhagat G; Jobanputra V
J Mol Diagn; 2018 Nov; 20(6):822-835. PubMed ID: 30138725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
